- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07859397
Comparison of Analgesic Effects of ACB Versus ACB Combined With BiFeS Block in ACL Reconstruction Surgery
Comparison of Postoperative Analgesic Effects of Adductor Canal Block Versus Adductor Canal Block Combined With Biceps Femoris Short Head Block in Patients Undergoing Anterior Cruciate Ligament Reconstruction Surgery
Anterior cruciate ligament (ACL) reconstruction is commonly associated with moderate to severe postoperative pain, particularly during the early postoperative period and rehabilitation. Effective postoperative analgesia is important to facilitate early mobilization, improve patient comfort, and reduce opioid consumption and opioid-related adverse effects.
Adductor canal block (ACB) is commonly used as part of multimodal analgesia for knee surgery because it provides analgesia while largely preserving quadriceps motor function. However, ACB primarily targets the anteromedial aspect of the knee and may provide limited analgesia for pain arising from the posterior and posterolateral knee.
The biceps femoris short head (BiFeS) block is a motor-sparing fascial plane block targeting sensory contributions to the posterolateral knee region. Combining BiFeS block with ACB may therefore provide more comprehensive analgesia than ACB alone.
This randomized study aims to compare the postoperative analgesic efficacy of adductor canal block alone with adductor canal block combined with BiFeS block in patients undergoing anterior cruciate ligament reconstruction surgery.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Atakan Sezgi
- Telefonnummer: 00905323327000
- E-post: kansezgi@gmail.com
Studera Kontakt Backup
- Namn: Jülide Ergil
- Telefonnummer: 00905323469216
- E-post: julideergil@hotmail.com
Studieorter
-
-
-
Ankara, Turkiet (Türkiye), 06170
- Rekrytering
- Ankara Etlik City Hospital
-
Kontakt:
- Atakan Sezgi, MD
- Telefonnummer: 00905323327000
- E-post: kansezgi@gmail.com
-
Kontakt:
- Jülide Ergil, Professor
- Telefonnummer: 00905323469216
- E-post: julideergil@hotmail.com
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Patients aged 18-65 years
- Patients scheduled for elective unilateral anterior cruciate ligament reconstruction surgery
- American Society of Anesthesiologists physical status I-III
- Patients who provide written informed consent
Exclusion Criteria:
- Age <18 or >65 years
- ASA physical status IV or higher
- Coagulopathy or ongoing anticoagulant therapy incompatible with peripheral nerve block
- Infection at the block injection site
- Patient refusal
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Adductor Canal Block Group
After induction of general anesthesia, an ultrasound-guided adductor canal block will be performed on the operative side. A linear ultrasound transducer will be placed transversely over the mid-thigh to identify the sartorius muscle, femoral artery, vastus medialis muscle, and adductor canal. A block needle will be advanced using an in-plane technique. After negative aspiration, 10 mL of 0.25% bupivacaine will be injected into the adductor canal. Appropriate spread of the local anesthetic will be confirmed by ultrasound imaging. All patients will receive standardized postoperative multimodal analgesia consisting of intravenous paracetamol 1 g every 8 hours and intravenous dexketoprofen 50 mg twice daily. |
Ultrasound-guided adductor canal block will be performed using 10 mL of 0.25% bupivacaine. |
|
Aktiv komparator: Adductor Canal Block + BiFeS Block Group
After induction of general anesthesia, an ultrasound-guided adductor canal block will first be performed on the operative side using the same technique as in the adductor canal block group. Subsequently, an ultrasound-guided biceps femoris short head (BiFeS) block will be performed. The ultrasound transducer will be positioned at the distal thigh to identify the short head of the biceps femoris muscle and the lateral femoral cortex. A block needle will be advanced using an in-plane technique toward the fascial plane between the biceps femoris short head muscle and the lateral femoral cortex. After negative aspiration, local anesthetic will be injected into this fascial plane, and adequate spread will be confirmed using ultrasound imaging. All patients will receive standardized postoperative multimodal analgesia consisting of intravenous paracetamol 1 g every 8 hours and intravenous dexketoprofen 50 mg twice daily. |
Ultrasound-guided adductor canal block will be performed using 10 mL of 0.25% bupivacaine. Ultrasound-guided BiFeS block will be performed using 20 mL of 0.25% bupivacaine. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Pain Score
Tidsram: On the operation day
|
Pain will be assessed at rest using the visual analog scale on a scale from 0 (no pain) to 100 (worst pain). Pain assessment will be done at 6th hour after surgery. |
On the operation day
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Pain Scores
Tidsram: On the operation day
|
Pain will be assessed at rest using the visual analog scale on a scale from 0 (no pain) to 100 (worst pain). Pain assessment will be done at 0st, 1st, 2nd, 12th, and 24th hours after surgery. |
On the operation day
|
|
Total Postoperative Morphine Consumption During the First 24 Hours AfterSurgery
Tidsram: On the operation day
|
Total Postoperative Morphine Consumption During the First 24 HoursAfter Surgery |
On the operation day
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- AEŞH-EK-2026-208
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .